X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs VENUS REMEDIES - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA VENUS REMEDIES SANOFI INDIA/
VENUS REMEDIES
 
P/E (TTM) x 30.0 -822.3 - View Chart
P/BV x 5.3 0.2 2,201.6% View Chart
Dividend Yield % 1.7 0.0 -  

Financials

 SANOFI INDIA   VENUS REMEDIES
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
VENUS REMEDIES
Mar-16
SANOFI INDIA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs4,560218 2,091.7%   
Low Rs4,40082 5,359.3%   
Sales per share (Unadj.) Rs1,028.5365.6 281.3%  
Earnings per share (Unadj.) Rs129.01.5 8,678.4%  
Cash flow per share (Unadj.) Rs186.037.9 490.4%  
Dividends per share (Unadj.) Rs68.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs753.6382.5 197.0%  
Shares outstanding (eoy) m23.0311.44 201.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.40.4 1,061.4%   
Avg P/E ratio x34.7101.0 34.4%  
P/CF ratio (eoy) x24.14.0 608.8%  
Price / Book Value ratio x5.90.4 1,515.5%  
Dividend payout %52.70-   
Avg Mkt Cap Rs m103,1741,717 6,010.5%   
No. of employees `0003.61.0 355.2%   
Total wages/salary Rs m3,592324 1,107.3%   
Avg. sales/employee Rs Th6,537.74,100.7 159.4%   
Avg. wages/employee Rs Th991.4318.0 311.7%   
Avg. net profit/employee Rs Th819.816.7 4,918.6%   
INCOME DATA
Net Sales Rs m23,6864,183 566.3%  
Other income Rs m70820 3,522.4%   
Total revenues Rs m24,3944,203 580.4%   
Gross profit Rs m5,281812 650.7%  
Depreciation Rs m1,313417 315.0%   
Interest Rs m15380 3.9%   
Profit before tax Rs m4,66135 13,279.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,69118 9,342.5%   
Profit after tax Rs m2,97017 17,470.6%  
Gross profit margin %22.319.4 114.9%  
Effective tax rate %36.351.6 70.4%   
Net profit margin %12.50.4 3,085.1%  
BALANCE SHEET DATA
Current assets Rs m15,6732,771 565.7%   
Current liabilities Rs m6,6781,931 345.8%   
Net working cap to sales %38.020.1 189.3%  
Current ratio x2.31.4 163.6%  
Inventory Days Days76125 60.8%  
Debtors Days Days2254 41.5%  
Net fixed assets Rs m8,0985,328 152.0%   
Share capital Rs m230114 201.3%   
"Free" reserves Rs m17,0884,177 409.1%   
Net worth Rs m17,3564,376 396.6%   
Long term debt Rs m01,911 0.0%   
Total assets Rs m25,4008,428 301.4%  
Interest coverage x311.71.1 28,536.1%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.5 187.9%   
Return on assets %11.84.7 249.6%  
Return on equity %17.10.4 4,405.1%  
Return on capital %26.96.6 408.2%  
Exports to sales %24.50-   
Imports to sales %28.020.5 136.3%   
Exports (fob) Rs m5,801NA-   
Imports (cif) Rs m6,627858 772.1%   
Fx inflow Rs m7,1450-   
Fx outflow Rs m6,846858 797.6%   
Net fx Rs m299-858 -34.8%   
CASH FLOW
From Operations Rs m3,226469 688.1%  
From Investments Rs m-1,55529 -5,325.3%  
From Financial Activity Rs m-1,818-464 392.2%  
Net Cashflow Rs m-14735 -426.1%  

Share Holding

Indian Promoters % 0.0 32.9 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 0.2 8,000.0%  
FIIs % 14.6 0.6 2,517.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 66.4 15.8%  
Shareholders   15,184 20,121 75.5%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   CIPLA  PFIZER  ALEMBIC PHARMA  SHASUN PHARMA  NOVARTIS  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 22, 2017 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS